Cargando…
Non-Small Cell Lung Cancer with Malignant Pleural Effusion May Require Primary Tumor Radiotherapy in Addition to Drug Treatment
PURPOSE: The impact of primary tumour radiotherapy on the prognosis for non-small-cell lung cancer (NSCLC) with controlled malignant pleural effusion (MPE-C) (MPE-C-NSCLC) is unclear. This study aimed to analyze the efficacy and safety of primary tumor radiotherapy in patients with MPE-C-NSCLC. PATI...
Autores principales: | Li, Qingsong, Hu, Cheng, Su, Shengfa, Ma, Zhu, Geng, Yichao, Hu, Yinxiang, Li, Huiqin, Lu, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716933/ https://www.ncbi.nlm.nih.gov/pubmed/36465711 http://dx.doi.org/10.2147/CMAR.S385818 |
Ejemplares similares
-
Failure pattern and radiotherapy exploration in malignant pleural effusion non-small cell lung cancer treated with targeted therapy
por: Li, Qingsong, et al.
Publicado: (2023) -
Impact of thoracic tumor radiotherapy on survival in non‐small‐cell lung cancer with malignant pleural effusion treated with targeted therapy: Propensity score matching study
por: Li, Qingsong, et al.
Publicado: (2023) -
Reasonable Timing of Radiotherapy for Stage IV Non-Small-Cell Lung Cancer During Targeted Therapy Based on Tumour Volume Change
por: Li, Qingsong, et al.
Publicado: (2021) -
The survival outcomes and prognosis of stage IV non-small-cell lung cancer treated with thoracic three-dimensional radiotherapy combined with chemotherapy
por: Su, ShengFa, et al.
Publicado: (2014) -
Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review
por: Zhang, Man, et al.
Publicado: (2021)